Home > Clinical Quality Assurance Services
CLINICAL QUALITY ASSURANCE SERVICES
BioBoston CRO provides clinical quality assurance services for sponsors that need independent oversight, risk based quality planning, audit support, inspection preparation, clinical CAPA remediation, or Trial Master File review. Support can be scoped around one study, vendor, system, inspection, finding, or quality workstream.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston team member.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
SERVICES
Develop or assess the sponsor's framework, plans, responsibilities, risk-based checks, governance
evidence, and follow-up for delegated clinical activities.
Use when the sponsor must demonstrate accountability for work performed by a Contract Research
Organization, vendor, site network, or specialist provider.
Conduct a structured simulation of document requests, interviews, process walkthroughs, observations,
debriefing, and readiness remediation.
Use when a clinical program, site, vendor, or sponsor team needs to test inspection readiness under realistic conditions.
Develop or strengthen clinical quality plans, risk-based quality management, review cadence, quality indicators, issue governance, and escalation controls.
Use when the study needs a practical quality framework connected to actual risks and operating decisions.
Investigate Good Clinical Practice issues, define root cause, establish corrective and preventive actions, document evidence, and plan effectiveness checks.
Use after audit findings, inspection observations, protocol or process deviations, vendor issues, or recurring quality failures.
Plan and perform risk-based audits of investigator sites, clinical vendors, processes, systems, or study
activities against the defined Good Clinical Practice scope.
Use when independent assurance is needed beyond routine monitoring or operational review.
Assess Trial Master File and electronic Trial Master File completeness, quality, timeliness, filing,
reconciliation, and inspection readiness using a defined sampling strategy.
Use during study conduct, before important milestones, at closeout, after transfer, or when file quality has
become uncertain.
Facilitate a focused assessment of critical processes, data, vendors, sites, controls, quality indicators, and planned mitigation.
Establish a proportionate cadence for reviewing quality risks, issues, actions, decisions, and escalations across sponsor functions and vendors.
Provide a defined second-line review of plans, records, responses, remediation evidence, or readiness materials without duplicating operational execution.
Common Triggers
Desired outcomes
Provide an independent, documented view of risks, outsourced activities, records, issues, and follow-up.
Direct effort toward the processes, data, sites, vendors, and decisions that could materially affect participants, data reliability, or regulatory credibility.
Improve retrieval, role clarity, interview preparation, evidence consistency, and remediation prioritization without promising an inspection outcome.
Connect findings to defensible root cause, proportionate actions, accountable owners, evidence, and effectiveness checks.
RELATED SERVICES
Manage operational performance, key performance indicators, meeting cadence, deliverables, issues, and escalation for clinical vendors.
Document sponsor, Contract Research Organization, vendor, and functional responsibilities, handoffs, decisions, and approvals.
Address data-management plans, electronic data capture, case-report forms, reconciliation, database lock, and data-control interfaces.
Coordinate clinical-operations strategy, vendor and site interfaces, monitoring models, and study-execution support through the confirmed delivery model.
Track quality actions, milestones, dependencies, risks, decisions, budgets, and cross-functional follow through.
deliverables
Approach
BioBoston defines the quality question, study and vendor context, applicable procedures, known risks,
intended use of the work, independence requirements, access to evidence, and decision owners before
confirming the scope. That prevents a broad quality review from becoming an unfocused document
exercise.
The sponsor retains accountability for clinical quality, vendor oversight, regulatory representations, and
corrective actions. BioBoston can provide independent assessment, facilitation, auditing, simulation,
documentation, and remediation support through the sponsor’s approved quality system and governance
process.
Process
1. Confirm the quality objective, study scope, vendors or sites, applicable procedures, risks, known findings, milestones, and required independence.
2. Review plans, records, contracts, oversight evidence, quality data, prior findings, Trial Master File status, and relevant process documentation.
3. Develop the risk-based oversight, audit, mock-inspection, quality-management, CAPA, or Trial Master File work plan.
4. Perform the agreed assessment, interviews, evidence review, simulation, facilitation, or remediation activities.
5. Document observations, findings, root causes, actions, decisions, limitations, and recommended priorities through the sponsor's review process.
6. Support response, remediation, effectiveness review, governance follow-up, or inspection-readiness activities as defined in scope..
Quality assurance becomes most valuable when it provides independent visibility into whether responsibilities, risks, records, vendors, sites, and corrective actions are being managed as intended.
Establish proportionate plans, responsibilities, oversight evidence, issue management, and inspection readiness practices without copying an enterprise system that does not fit the program.
Create independent visibility across outsourced activities and document how risks, quality issues, decisions, and follow-up are governed.
Assess readiness, rehearse responses, review essential records, identify gaps, and prioritize remediation before the external event.
Expertise
Quality expertise should match the study phase, product type, audit or inspection scope, vendor and site
model, Trial Master File environment, issue history, and applicable procedures. Use an approved expert
profile and, when permitted, one specific testimonial or anonymized example rather than generic quality
claims.
RESOURCES
A planned checklist for delegated activities, plans, responsibilities, evidence, risk review, governance, issues, and follow-up.
A planned guide to scope, document requests, interviews, process walkthroughs, observations, debriefing, and remediation.
A planned resource covering milestones, scope, risk, sampling, completeness, quality, filing, timeliness, and follow-up.
FAQs
Sponsor Oversight focuses on sponsor accountability, compliance oversight, plans, risk-based checks, and evidence that delegated activities are controlled. Vendor Governance focuses on operational performance, key performance indicators, meetings, delivery, issues, and escalation.
No. A Good Clinical Practice audit independently assesses a defined process, site, vendor, system, or
study scope. A mock inspection simulates inspection behavior, document requests, interviews,
walkthroughs, and readiness response under a broader inspection scenario.
Yes. TMF Audits has its own Tier 2 page and focuses on Trial Master File or electronic Trial Master File
completeness, quality, timeliness, filing, reconciliation, and inspection readiness.
Yes. Support may include response review, root-cause analysis, clinical CAPA development, evidence
expectations, action tracking, and effectiveness-check planning. The sponsor remains responsible for
approving and implementing the response.
No. Independent review and preparation can identify gaps and strengthen readiness, but an authority
determines the inspection scope, observations, and outcome.
Useful inputs include the study and vendor scope, applicable procedures, contracts and responsibilities, quality plans, risk assessments, prior findings, oversight evidence, Trial Master File status, target milestone, and access to relevant records and personnel.
PROJECT FORM
Share the study or vendor scope, known risks or findings, upcoming audit or inspection milestone, and the type of quality support you need. A BioBoston team member will review the request and follow up regarding fit and possible next steps.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
A productive first discussion identifies the study, vendors or sites, quality concern, evidence available, applicable procedures, independence required, and next milestone. BioBoston can then define the appropriate oversight, audit, readiness, CAPA, quality-management, or Trial Master File scope.
